ABT-122 clinical trials

Studies by the year they started

5 studies that test it; most in 2015 (3)

Who runs them

Industry 5 · Other 0

AbbVie (5)

Studies

Open first, then newest update. How each study uses ABT-122 is read from its arms, and is right about nine times in ten.

Testing it · 5

• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid ArthritisCompletedPhase 1AbbVieNCT01853033Written as ABT-122
• A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)CompletedPhase 2AbbVieNCT02349451Written as ABT-122
• Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 StudyCompletedPhase 2AbbVieNCT02433340Written as ABT-122
• A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedPhase 2AbbVieNCT02141997Written as ABT-122
• A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197TerminatedPhase 2AbbVieNCT02429895Written as ABT-122

Codes

What other systems call ABT-122 · ClinicalTrials.gg INT000848

• MeSH (NLM) C000625317ABT-122One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.